Related Experiment Video
Updated: Feb 17, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
PAQR4 has a tumorigenic effect in human breast cancers in association with reduced CDK4 degradation
Huanhuan Zhang1,2, Ruomei Han1,2, Zhi-Qiang Ling3
1Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, China.
Abstract:
Progestin and adipoQ receptor 4 (PAQR4) is a member of the PAQR family, and the members within this family are involved in the regulation of a number of biological processes including metabolism and cancer development. The potential function of PAQR4 in human cancers is unknown. Analysis of ONCOMINE database reveals that PAQR4 is highly expressed in human breast cancers. We confirmed this finding by analyzing 82 human breast cancers samples. PAQR4 mRNA level was significantly upregulated in human breast cancer samples compared with their corresponding para-cancerous histological normal tissues (P < 0.0001). The mRNA level of PAQR4 was negatively correlated with disease-free survival (P < 0.0001) and overall survival of the patients (P = 0.001). Knockdown of PAQR4 in human breast cancer cells SUM159 and MCF7 suppressed cell proliferation. In contrast, overexpression of PAQR4 in SUM159 cells enhanced cell proliferation and colony formation. In a tumor xenograft model, overexpression of PAQR4 promoted tumor growth of SUM159 cells in vivo, while PAQR4 knockdown suppressed the tumor growth. PAQR4 was able to negatively regulate cyclin-dependent kinases 4 (CDK4) protein level in the breast cancer cells. Knockdown of PAQR4 accelerated degradation of CDK4 together with upregulation of CDK4 polyubiquitination. On the other hand, overexpression of PAQR4 slowed down CDK4 protein degradation and reduced CDK4 polyubiquitination. Collectively, these data at the cellular, animal and human levels indicate that PAQR4 has a tumorigenic effect on human breast cancers, and such effect is associated with a modulatory activity of PAQR4 on protein degradation of CDK4.
Insights
Progestin and adipoQ receptor 4 (PAQR4) promotes breast cancer growth by increasing cell proliferation and tumor formation. It also affects cyclin-dependent kinases 4 (CDK4) protein levels, impacting patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Progestin and adipoQ receptor 4 (PAQR4) is part of a family involved in metabolism and cancer.
- The role of PAQR4 in human cancers, particularly breast cancer, is not well understood.
Purpose of the Study:
- To investigate the function of PAQR4 in human breast cancer development and progression.
- To explore the molecular mechanisms underlying PAQR4's role in breast cancer.
Main Methods:
- Analysis of PAQR4 expression in human breast cancer tissues using the ONCOMINE database and patient samples.
- In vitro studies involving PAQR4 knockdown and overexpression in breast cancer cell lines (SUM159, MCF7) to assess proliferation and colony formation.
- In vivo tumor xenograft models to evaluate the effect of PAQR4 on tumor growth.
- Investigation of PAQR4's impact on cyclin-dependent kinases 4 (CDK4) protein levels, degradation, and polyubiquitination.
Main Results:
- PAQR4 is significantly upregulated in human breast cancer tissues compared to normal tissues.
- Higher PAQR4 mRNA levels correlate with poorer disease-free and overall survival in breast cancer patients.
- PAQR4 overexpression enhances breast cancer cell proliferation, colony formation, and tumor growth in vivo.
- PAQR4 knockdown suppresses these processes.
- PAQR4 negatively regulates CDK4 protein levels by modulating its degradation and polyubiquitination.
Conclusions:
- PAQR4 exhibits a tumorigenic effect in human breast cancer.
- PAQR4's oncogenic role is linked to its modulation of CDK4 protein stability.
- PAQR4 represents a potential therapeutic target for breast cancer treatment.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:34Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Positive Regulator Molecules